Summary: A revolutionary study has introduced Transcranial Radio Frequency Stimulation (TRFS), a non-invasive technique that uses precise radio waves to “dial” brain cell activity up or down. Unlike traditional methods that struggle with the skull’s density or depth of penetration, TRFS uses high-frequency signals to target specific deep-brain regions without surgery.
The research demonstrates that these waves can either suppress overactive neurons in conditions like depression and anxiety or excite them to counter Parkinson’s and epilepsy.
Key Facts
- The Technique: TRFS uses customized antennae (made from coaxial cable tips) to deliver radio frequency (RF) energy. This energy creates tiny, safe temperature shifts that change how ions flow in and out of neurons.
- Overcoming Limitations: Traditional non-invasive methods like TMS (magnetic) or ultrasound are often blocked by the skull or can’t reach deep-brain structures. RF energy penetrates biological tissue more effectively.
- Bimodal Action: TRFS operates in two distinct modes:
- Pristine Mode: Targets normal brain tissue to suppress inhibitory interneurons (the brain’s “brakes”). This is particularly effective for treating depression and chronic pain.
- RF-Genetics Mode: Combines RF waves with genetic engineering (adding TRPV1 “molecular thermometers” to cells). This allows researchers to specifically excite neural activity.
- Behavioral Proof: In mouse models, researchers were able to control the physical direction a mouse turned simply by applying TRFS to specific sides of the brain.
- Safety Profile: While people often fear RF (like cell phone radiation), the study found that while everyday doses are harmless, these higher “clinical” doses are safe and highly effective for medical modulation.
Source: NYU Langone
A new study found that precise application of radio waves can change the activity of brain cells in ways that could counter neurological conditions.
Led by researchers at NYU Langone Health, the work introduces a technique called Transcranial Radio Frequency Stimulation (TRFS), which promises to treat neurological diseases with neither the invasiveness of surgery nor the frequent failure of drugs as patients (e.g., 30 percent of people with depression and epilepsy) develop resistance.
Published online recently in the journal Brain Stimulation, the study describes the use of radio frequency, or RF, energy, which is effective at penetrating biological tissue. The study says TRFS could overcome the limits of older technologies because it can, depending on the nature of the disease, target either a small part of the brain or the entire organ, and it can dial nerve signaling up or down.
“Our study is the first to demonstrate in live mice the potential of the technology to be highly effective for adjusting neural activity,” said senior study author György Buzsáki, MD, PhD, the Biggs Professor of Neuroscience in the Department of Neuroscience at NYU Grossman School of Medicine.
“The need for better, noninvasive techniques is becoming ever more urgent, with 1 in 3 people globally affected by some form of brain disorder during their lifetime,” said Dr. Buzsáki, also faculty in the Institute for Translational Neuroscience.
Radio frequency waves have long been used in the brain as part of MRI imaging, which creates images by imposing and tracking changes in the energy states of atoms. Radio waves are also used to create heat that destroys cancer cells. Despite these uses, RF energy has not been explored for direct brain stimulation.
Although various transcranially delivered effects—electric (direct or alternating current), magnetic, and ultrasound—are used routinely for direct stimulation, each is limited by the nature of the energy used, how it interacts with tissue, or the head’s anatomy. Energy sent through contacts placed on the scalp, for instance, cannot focus on one small area. Stimulation applied by electromagnetic coils decays quickly with distance and cannot reach deep brain regions. The skull can interfere with ultrasound, causing side effects.
The study authors said they overcame such limitations by designing small, customized antennae made from the tips of coaxial cables. These antennae transmit high-frequency signals to precisely direct RF energy to deep-brain locations. RF delivered in this way heats targeted brain tissue, which changes how easily charged ions flow in and out of brain cells and influences signal strength.
TRFS was designed to work in two modes, the study authors said. Among the study’s main findings was that TRFS could be used to either suppress or encourage the signaling activity of brain cells.
Using a technique called 1-photon fiber photometry, the team recorded local heat-induced brain cell activity changes in study mice. The results showed that applying RF energy to the intact, normal brain, which they termed the “pristine mode,” had a particularly strong effect on brain cells called inhibitory interneurons.
Specialized to connect cells in circuits, inhibitory interneurons serve as the brakes on messages that travel from neuron to neuron, sculpting the brain signals into actions, perceptions, and thoughts.
The fact that RF energy has a strong effect on these cells is profound, the authors said, because suppressing them has been shown to counter depression, chronic pain, and anxiety disorders.
RF energy raised the temperature in normal interneurons and led to dose-dependent suppression of activity. The temperature changes were within the small, normal range for healthy cells (not in the damaging range).
In other experiments, the team showed that RF energy could also achieve the opposite effect, encouraging signaling levels in specifically targeted cell types. Called “RF-genetics mode,” this second approach combined RF energy with genetic engineering that added more transient receptor potential vanilloid 1 (TRPV1) ion channels to the surfaces of target cells. Known as molecular thermometers, TRPV1 channels render cells more sensitive to heat.
RF stimulation of TRPV1-overexpressing regions produced temperature-dependent excitation of neural activity once local temperature change exceeded 1.5 degrees Celsius. Past studies have suggested that increasing excitation in specific cell types can counter Parkinson’s disease, autism, epilepsy, addiction, and other conditions.
To demonstrate the capability of TRFS to change behavior in mice in both pristine and RF-genetics modes, the researchers targeted the striatal neurons known to control rightward or leftward turns. TRFS-driven neuromodulation changed the direction of rotation in freely moving mice, depending on which side of the brain the RF energy was applied to.
In pristine mode, mice tended to rotate toward the side of the head where the brain was being stimulated, whereas they did the opposite in RF-genetics mode.
“Interestingly, the widespread use of cell phones, and fears that they might affect brain function, resulted in a massive body of research literature on the effect of RF energy on the brain,” said lead study author Omid Yaghmazadeh, PhD, a former postdoctoral scholar in the Buzsáki Lab.
“Our previous work showed that everyday RF doses do not in fact affect neuronal activity, and now we show that higher, yet safe, doses can be harnessed for neuromodulation,” said Dr. Yaghmazadeh, now an assistant professor in the Department of Electrical and Computer Engineering at Boise State University with a newly established lab.
Along with Drs. Buzsáki and Yaghmazadeh, study authors were Jiangyang Zhang, PhD, Leeor Alon, PhD, and Zakia Ben Youss in the Department of Radiology at NYU Grossman School of Medicine, as well as Tanzil M. Arefin, PhD, in the Department of Neuroscience at the University of Rochester Medical Center.
Funding: The work was supported by the National Institutes of Health grant 1R01NS113782-01A1.
Key Questions Answered:
A: Not at all. The heat produced is incredibly subtle—within the normal, healthy range of temperature fluctuations cells experience every day. It’s just enough of a “nudge” to change how the cell’s “gates” (ion channels) open and close, allowing doctors to tune the brain’s electrical signals like a radio.
A: Neuralink and deep brain stimulation (DBS) are invasive—they require drilling into the skull and inserting wires. TRFS aims to provide that same level of deep-brain precision from the outside. For the 30% of patients who don’t respond to drugs, this offers a middle ground between pills and major surgery.
A: The researchers are specifically looking at clinical disorders like epilepsy, Parkinson’s, and major depression. Because it can target the “inhibitory interneurons”—the cells that sculpt our thoughts and perceptions—it has massive potential for correcting the “misfires” that cause anxiety and chronic pain.
Editorial Notes:
- This article was edited by a Neuroscience News editor.
- Journal paper reviewed in full.
- Additional context added by our staff.
About this neuromodulation and neurotech research news
Author: Gregory Williams
Source: NYU Langone
Contact: Gregory Williams – NYU Langone
Image: The image is credited to Neuroscience News
Original Research: Open access.
“Non-invasive modulation of brain activity and behavior by transcranial radio frequency stimulation” by Omid Yaghmazadeh, Leeor Alon, Tanzil M. Arefin, Zakia Ben Youss, Jiangyang Zhang, and György Buzsáki. Brain Stimulation
DOI:10.1016/j.brs.2026.103032
Abstract
Non-invasive modulation of brain activity and behavior by transcranial radio frequency stimulation
Background
Achieving non-invasive, targeted modulation of deep brain tissue remains a major challenge in neurotechnology. Current non-invasive brain stimulation methods—such as transcranial electrical (TES), magnetic (TMS), and focused ultrasound (TFUS) stimulation—suffer from limitations in spatial focality, penetration depth, or skull-related distortions.
Radio frequency (RF) energy, which penetrates biological tissue effectively, offers an alternative avenue for neural modulation. This study introduces Transcranial Radio Frequency Stimulation (TRFS) as a novel, non-invasive neuromodulation technique that leverages RF-induced thermal effects to modulate neural activity in vivo.
Methods
We developed a custom RF stimulation system using 945 MHz stub antennas optimized for localized brain heating in mice. Using our unique experimental setup, we developed and tested two operational modes of TRFS:Pristine mode: RF stimulation applied to intact brain tissue.RF-genetics mode: RF stimulation applied to brain regions virally transduced to overexpress the thermosensitive TRPV1 ion channel.
Neural activity was recorded using metal-free one-photon fiber photometry with GCaMP calcium indicators. Behavioral effects were assessed through a rotational test in freely moving mice after MK-801-induced hyperlocomotion. Local temperature changes were monitored by optical thermometry.
Results
In pristine mode, RF exposure induced temperature rises leading to dose-dependent suppression of cortical parvalbumin (PV) interneuron activity. This neural suppression translated behaviorally into a unilateral rotational bias ipsilateral to the stimulated hemisphere in hyperlocomotive freely moving mice.In RF-genetics mode, RF stimulation of TRPV1-overexpressing regions produced temperature-dependent excitation of neural activity once local change in temperatures exceeded ΔT ≈ 1.5 °C. Behaviorally, this excitation reversed the direction of rotation in hyperlocomotive freely moving mice, yielding a contralateral bias.
Conclusions
TRFS represents a conceptual advance in neuromodulation, uniting the inherent capability of RF energy to target deep brain tissue with the biophysical reliability of thermal modulation. TRFS applications are bimodal, capable of influencing the pristine brain by suppressing the activity of specific neuronal populations in targeted regions, or of exciting selectively transfected neural ensembles expressing thermosensitive TRPV1 ion channels.
The latter modality, first introduced here, represents a novel concept termed “RF-genetics.” TRFS represents a promising platform for next-generation non-invasive brain stimulation with potential translational applications in treating various neurological and psychiatric disorders.
